Nucleate Philly reposted this
Are you an academic trainee (Post-doc/PhD/MBA/MD/JD/MS) eager to build a life science startup? Whether you're passionate about therapeutics, diagnostics, medtech, synthetic biology, or fields like food, energy, agriculture, climate, or consumer products, this is your opportunity to transform your research into a groundbreaking venture! Over the past five years, Nucleate's Activator Program has supported more than 409 venture teams, with our alumni raising over $370M to develop cutting-edge technologies. Demetri Maxim and his team participated in the Nucleate New York 2022-2023 Activator Program, and their company, Nephrogen, is now a VC-backed seed-stage biotech company developing curative gene therapies for kidney diseases. Nephrogen has since won $100,000 in the Nucleate Alnylam Pharmaceuticals BioVenture Challenge and has been awarded the Bristol Myers Squibb Golden Ticket, the Otsuka Pharmaceutical Companies (U.S.) Golden Ticket, and the Chiesi Group Golden Ticket at Biolabs@NYULangone @ NYU Langone. This year, they also received the 2024 MilliporeSigma North American Research Grant. Interested in particpating in the 2024-2025 Activator? 📅 Application Deadline: Nov 6th, 2024 🔗 Application: apply.nucleate.org 🌐 Learn more: nucleate.org/activator
